# Beneficial Effects of Supplementation With CRONILIEF™ (Palmitoylethanolamide Phospholipids) in Diabetic Subjects With Neuropathic Pain.

> **NCT07377409** · NA · NOT_YET_RECRUITING · sponsor: **Azienda di Servizi alla Persona di Pavia** · enrollment: 70 (estimated)

## Conditions studied

- Neuropathic Pain Management
- Diabetic Neuropathies, Painful
- Palmitoylethanolamide

## Interventions

- **DIETARY_SUPPLEMENT:** Cronilief™ (300 mg)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07377409
- **Lead sponsor:** Azienda di Servizi alla Persona di Pavia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2026-12-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377409, "Beneficial Effects of Supplementation With CRONILIEF™ (Palmitoylethanolamide Phospholipids) in Diabetic Subjects With Neuropathic Pain.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07377409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*